A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant …
C Zhang, Z Zhang, G Zhang, L Xue… - Clinical and …, 2020 - Wiley Online Library
Background Current strategies are insufficient to predict pathologically complete response
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant …
C Zhang, Z Zhang, G Zhang, L Xue, H Yang… - Clinical and …, 2020 - go.gale.com
Background: Current strategies are insufficient to predict pathologically complete response
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
[HTML][HTML] A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant …
C Zhang, Z Zhang, G Zhang, L Xue… - Clinical and …, 2020 - ncbi.nlm.nih.gov
Background Current strategies are insufficient to predict pathologically complete response
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant …
C Zhang, Z Zhang, G Zhang, L Xue… - Clinical and …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Current strategies are insufficient to predict pathologically complete response
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant …
C Zhang, Z Zhang, G Zhang, L Xue, H Yang… - Clinical and …, 2020 - europepmc.org
Background Current strategies are insufficient to predict pathologically complete response
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant …
C Zhang, Z Zhang, G Zhang, L Xue, H Yang… - Clinical and …, 2020 - europepmc.org
Background Current strategies are insufficient to predict pathologically complete response
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …
(pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to …